HLS Therapeutics Inc. (TSX:HLS)
3.920
-0.110 (-2.73%)
Aug 10, 2026, 4:00 PM EST
HLS Therapeutics Employees
HLS Therapeutics had 85 employees as of December 31, 2025. The number of employees decreased by 7 or -7.61% compared to the previous year.
Employees
85
Change (1Y)
-7
Growth (1Y)
-7.61%
Revenue / Employee
915.37K CAD
Profits / Employee
-169.00K CAD
Market Cap
122.60M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 85 | -7 | -7.61% |
| Dec 31, 2024 | 92 | 1 | 1.10% |
| Dec 31, 2023 | 91 | -8 | -8.08% |
| Dec 31, 2022 | 99 | 7 | 7.61% |
| Dec 31, 2021 | 92 | 4 | 4.55% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Ascend Wellness Holdings | 2,300 |
| Organigram Global | 1,120 |
| TerrAscend | 1,038 |
| Cannara Biotech | 452 |
| Charlotte's Web Holdings | 112 |
| Medexus Pharmaceuticals | 90 |
| Cardiol Therapeutics | 18 |
HLS Therapeutics News
- 6 weeks ago - HLS Therapeutics Transcript: AGM 2026 - Transcripts
- 2 months ago - HLS Therapeutics Slides: Investor presentation - Filings
- 2 months ago - HLS Therapeutics resumed with a Hold at Canaccord - TheFly
- 3 months ago - HLS Therapeutics Earnings Call Transcript: Q1 2026 - Transcripts
- 3 months ago - HLS Therapeutics Earnings release: Q1 2026 - Filings
- 3 months ago - HLS Therapeutics Slides: Q1 2026 - Filings
- 3 months ago - HLS Therapeutics Slides: Corporate presentation - Filings
- 3 months ago - HLS Therapeutics Transcript: 2026 Bloom Burton & Co. Healthcare Investor Conference - Transcripts